BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3997598)

  • 1. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
    Born JL; Hadley WM
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver.
    Smith BR; Born JL
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1365-70. PubMed ID: 6469758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
    Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
    Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
    McManus ME; Monks A; Collins JM; White R; Strong JM
    J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.
    Akel G; Benard P; Canal P; Soula G
    Cancer Chemother Pharmacol; 1986; 17(2):121-6. PubMed ID: 3719893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
    Workman P; Donaldson J; Smith NC
    Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA; Workman P
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The penetration of misonidazole into a mature structural cartilage.
    Langler AJ; Bugden RD; Gibson P
    Br J Cancer; 1982 Feb; 45(2):282-5. PubMed ID: 7059476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.
    Sheldon PW; Clarke C; Dawson KB
    Br J Cancer; 1984 Feb; 49(2):207-13. PubMed ID: 6696821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
    Hirst DG; Hazlehurst JL; Brown JM
    Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
    Honess DJ; Workman P; Morgan JE; Bleehen NM
    Br J Cancer; 1980 Apr; 41(4):529-40. PubMed ID: 7387851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
    Eifel PJ; Brown DM; Lee WW; Brown JM
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse.
    Cobb LM; Nolan J; Butler S
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):347-51. PubMed ID: 2303365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
    Eifel PJ; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-pharmacokinetic relationships for misonidazole analogues in mice.
    Workman P; Brown JM
    Cancer Chemother Pharmacol; 1981; 6(1):39-49. PubMed ID: 7273265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.